Covance, Inc. (NYSE:CVD)
| CAPS Rating |
|
|---|---|
| Open | $47.15 |
| Previous Close | $47.03 |
| Daily Range | $46.32 - $47.15 |
| 52-Week Range | $42.02 - $63.86 |
| Market Cap | $2.83B |
| P/E Ratio | 42.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 780,049 |
| Average Daily Volume | 0 |
How do you think CVD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CVD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CVD News and Commentary
- Charges Spoil Covance's 4Q - Analyst Blog – NASDAQ
- Covance Shares Slumped: What You Need to Know – The Motley Fool
- Covance Beats Estimates but Has a Dismal Quarter – The Motley Fool
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Covance Earnings Preview – The Motley Fool
- Don't Get Too Worked Up Over ICON's Earnings – The Motley Fool
- Are Shorts Watching Pharmaceutical Product Development? – The Motley Fool
- Covance Earnings Preview – The Motley Fool
- Should You Get Out of ICON Before Next Quarter? – The Motley Fool
- Pharmaceutical Product Development Shares Soared: What You Need to Know – The Motley Fool
- 1 Special Stock Pick From an Outside View – The Motley Fool
- Is PAREXEL International Going to Burn You? – The Motley Fool
- Here's How Covance Is Making You So Much Cash – The Motley Fool
- Is ICON the Perfect Stock? – The Motley Fool
- The 15 Most-Watched Life-Sciences Stocks – The Motley Fool
- Covance's CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Rising Stars Buy: Icon – The Motley Fool
- Is Private Equity Interested in Buying PPD? – The Motley Fool
- Is Covance a Fast Cash Machine? – The Motley Fool

RSS Headlines
Fool UK